Biotech

All Articles

Boundless Biography produces 'reasonable' cutbacks five months after $100M IPO

.Only five months after protecting a $100 million IPO, Boundless Biography is actually actually layi...

Halda's $126M is going to progress 'keep and also eliminate' growth medications

.The initial stages of oncology R&ampD may not be short of appealing brand-new methods, and Halda Th...

Lykos 'disappointments' not divulging research study transgressions along with author

.Psychopharmacology has pulled three articles about midstage scientific trial data evaluating Lykos ...

Analysts dig into Avidity's DMD gain, showing distinctions in information

.Avidity Biosciences satisfied investors with stage 1/2 information in Duchenne muscular dystrophy (...

Actinogen's cortisol blocker fails period 2 depression research study

.Actinogen Medical's cortisol blocker has overlooked the main endpoint of a stage 2 research in clin...

Bivictrix decides going exclusive only way to take ADC right into clinic

.Antibody-drug conjugates (ADCs) have gone to the center of a lot of a billion-dollar biobuck licens...

TPG tops up funds to $580M for financial investments throughout life sciences

.Asset manager TPG, which has assisted biotechs like Sionna Rehabs and also Santa Ana Biography, has...

Merck stops period 3 TIGIT trial in bronchi cancer for futility

.Merck &amp Co.'s TIGIT plan has actually suffered yet another drawback. Months after shuttering a s...

After a challenging year, Exscientia folds in to Recursion

.After a year specified through pipe hairstyles, the shift of its own CEO and also layoffs, Exscient...

Cullinan, after $25M package, hands back bispecific to Harbour

.Cullinan Therapeutics was actually excited good enough with Harbour BioMed's bispecific immune syst...